Form 13G TriSalus Life Sciences For: 20 May
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TriSalus Life Sciences Inc (TLSI)
TriSalus Life Sciences Inc stock price live, this page displays NASDAQ TLSI stock exchange data. View the TLSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TriSalus Life Sciences Inc real time stock price chart below.
What Is the TriSalus Life Sciences Inc Stock Price Today?
The TriSalus Life Sciences Inc stock price today is 3.170.
What Is the Stock Symbol for TriSalus Life Sciences Inc?
The stock symbol for TriSalus Life Sciences Inc is "TLSI."
What Stock Exchange Does TriSalus Life Sciences Inc Trade On?
TriSalus Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is TriSalus Life Sciences Inc a Good Stock to Buy?
Determining whether TriSalus Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLSI quote. (ISIN: US89680M1018)
What Is the TriSalus Life Sciences Inc Stock Price Today?
The TriSalus Life Sciences Inc stock price today is 3.170.
What Is the Stock Symbol for TriSalus Life Sciences Inc?
The stock symbol for TriSalus Life Sciences Inc is "TLSI."
What Stock Exchange Does TriSalus Life Sciences Inc Trade On?
TriSalus Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is TriSalus Life Sciences Inc a Good Stock to Buy?
Determining whether TriSalus Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLSI quote. (ISIN: US89680M1018)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.160
3.330
52 wk Range
2.200
7.950
TLSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1603.330
52 wk Range
2.2007.950
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TLSI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
8.800
Upside
+177.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 13G TriSalus Life Sciences For: 15 May
- Investing.com
- Form 13G TriSalus Life Sciences For: 20 May
- Investing.com
- Form 13G TriSalus Life Sciences For: 15 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.800
(+177.60% Upside)
TriSalus Life Sciences Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue fell 3.3% YoY to $8.9M; gross margin improved to 86% from 84%; cash position remains strong at $56.6M
- Net operating loss widened to $8.4M from $7.3M; adjusted EBITDA loss increased to $5.8M vs $5.5M in prior year period
- Company published largest real-world evidence study validating Pressure-Enabled Drug Delivery (PEDD) technology platform
- FY2026 guidance: EPS -$0.41, revenue $53.45M (18% growth); FY2027 targets: EPS -$0.25, revenue $75M; FDA clearance expected H2 2026
- Stock down 62% YTD to $2.69 despite premarket gain; analysts rate 'Strong Buy' with $7-$11 price targets amid commercial realignment
Last Updated: 2026-05-18, 10:48 a/m
Read Full TranscriptEarnings
Latest Release
May 12, 2026
EPS / Forecast
0.03 / --
Revenue / Forecast
8.9M / 19.45M
Compare TLSI to Peers and Sector
Metrics to compare | TLSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | −2.2x | −0.5x | |
PEG Ratio | 0.24 | −0.11 | 0.00 | |
Price/Book | 15.2x | 3.1x | 2.6x | |
Price / LTM Sales | 4.3x | 108.8x | 3.0x | |
Upside (Analyst Target) | 152.4% | 182.4% | 58.7% | |
Fair Value Upside | Unlock | −2.6% | 10.3% | Unlock |
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the TriSalus Life Sciences (TLSI) Stock Price Today?
The TriSalus Life Sciences stock price today is 3.170 USD.
What Stock Exchange Does TriSalus Life Sciences Trade On?
TriSalus Life Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for TriSalus Life Sciences?
The stock symbol for TriSalus Life Sciences is "TLSI."
What Is the TriSalus Life Sciences Market Cap?
As of today, TriSalus Life Sciences market cap is 194.690M USD.
What Is TriSalus Life Sciences's Earnings Per Share (TTM)?
The TriSalus Life Sciences EPS (TTM) is -1.302.
When Is the Next TriSalus Life Sciences Earnings Date?
TriSalus Life Sciences will release its next earnings report on Aug 19, 2026.
From a Technical Analysis Perspective, Is TLSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has TriSalus Life Sciences Stock Split?
TriSalus Life Sciences has split 0 times.
How Many Employees Does TriSalus Life Sciences Have?
TriSalus Life Sciences has 102 employees.
What is the current trading status of TriSalus Life Sciences (TLSI)?
As of Jun 07, 2026, TriSalus Life Sciences (TLSI) is trading at a price of 3.170 USD, with a previous close of 3.300 USD. The stock has fluctuated within a day range of 3.160 USD to 3.330 USD, while its 52-week range spans from 2.200 USD to 7.950 USD.
What Is TriSalus Life Sciences (TLSI) Price Target According to Analysts?
The average 12-month price target for TriSalus Life Sciences is 8.800 USD, with a high estimate of 11 USD and a low estimate of 7 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +177.60% Upside potential.
What Is the TLSI Premarket Price?
TLSI's last pre-market stock price is 3.187 USD. The pre-market share volume is 110.000, and the stock has decreased by -0.113, or -3.420%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.